Commonwealth Equity Services’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $383K | Buy |
98,921
+9,245
| +10% | +$35.8K | ﹤0.01% | 3378 |
|
|
2025
Q1 | $448K | Buy |
89,676
+3,582
| +4% | +$17.9K | ﹤0.01% | 3113 |
|
|
2024
Q4 | $621K | Sell |
86,094
-3,026
| -3% | -$21.8K | ﹤0.01% | 2785 |
|
|
2024
Q3 | $547K | Buy |
89,120
+2,010
| +2% | +$12.3K | ﹤0.01% | 2827 |
|
|
2024
Q2 | $579K | Buy |
87,110
+7,165
| +9% | +$47.6K | ﹤0.01% | 2710 |
|
|
2024
Q1 | $814K | Buy |
79,945
+19,172
| +32% | +$195K | ﹤0.01% | 2401 |
|
|
2023
Q4 | $684K | Buy |
60,773
+19,763
| +48% | +$222K | ﹤0.01% | 2449 |
|
|
2023
Q3 | $107K | Buy |
41,010
+3,945
| +11% | +$10.3K | ﹤0.01% | 3556 |
|
|
2023
Q2 | $131K | Buy |
37,065
+6,696
| +22% | +$23.7K | ﹤0.01% | 3523 |
|
|
2023
Q1 | $128 | Buy |
30,369
+13,820
| +84% | +$58 | ﹤0.01% | 3441 |
|
|
2022
Q4 | $272K | Hold |
16,549
| – | – | ﹤0.01% | 2948 |
|
|
2022
Q3 | $211K | Buy |
+16,549
| New | +$211K | ﹤0.01% | 3117 |
|
|
2021
Q4 | – | Sell |
-19,255
| Closed | -$217K | – | 3646 |
|
|
2021
Q3 | $217K | Sell |
19,255
-482
| -2% | -$5.43K | ﹤0.01% | 3205 |
|
|
2021
Q2 | $194K | Buy |
19,737
+7,802
| +65% | +$76.7K | ﹤0.01% | 3275 |
|
|
2021
Q1 | $168K | Buy |
+11,935
| New | +$168K | ﹤0.01% | 3177 |
|
|
2018
Q3 | – | Sell |
-333
| Closed | -$4K | – | 2788 |
|
|
2018
Q2 | $4K | Hold |
333
| – | – | ﹤0.01% | 2761 |
|
|
2018
Q1 | $11K | Buy |
+333
| New | +$11K | ﹤0.01% | 2691 |
|